Global life sciences leader with 10+ years in oncology diagnostics and next-generation sequencing (NGS), driving global market strategy and product portfolio success of complex assay portfolios. Proven track record in maximizing in-market performance through cross-functional collaboration with R&D, commercial teams, and international affiliates as part of global International Business Teams (IBT). Expert at converting voice-of-customer insights into scalable, innovative solutions that drive adoption, revenue growth, and competitive advantage.